Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture

• Published in: Journal of virology Vol. 91; no. 15
• Main Authors: Ruedas, John B, Ladner, Jason T, Ettinger, Chelsea R, Gummuluru, Suryaram, Palacios, Gustavo, Connor, John H
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01-08-2017
• Subjects: Adaptation, Biological; Amino Acid Substitution; Animals; Cell Line; DNA Mutational Analysis; Ebolavirus - genetics; Ebolavirus - growth & development; Ebolavirus - physiology; Genome, Viral; Humans; Mutant Proteins - genetics; Mutation, Missense; Recombination, Genetic; Reverse Genetics; Selection, Genetic; Sequence Analysis, DNA; Serial Passage; Vesiculovirus - genetics; Vesiculovirus - growth & development; Viral Envelope Proteins - genetics; Virus Cultivation; Virus Internalization; Virus-Cell Interactions; Ebola virus; mutation; Tai Forest ebolavirus; tissue culture; virus entry; adaptation; glycoproteins; Sudan ebolavirus; tissue culture mutation; Bundibugyo ebolavirus; membrane fusion
• ISSN: 0022-538X; 1098-5514
• DOI: 10.1128/jvi.00392-17

Ebolaviruses have a surface glycoprotein (GP
) that is required for virus attachment and entry into cells. Mutations affecting GP
functions can alter virus growth properties. We generated a recombinant vesicular stomatitis virus encoding Ebola virus Makona variant GP
(rVSV-MAK-GP) and observed emergence of a T544I mutation in the Makona GP
gene during tissue culture passage in certain cell lines. The T544I mutation emerged within two passages when VSV-MAK-GP was grown on Vero E6, Vero, and BS-C-1 cells but not when it was passaged on Huh7 and HepG2 cells. The mutation led to a marked increase in virus growth kinetics and conferred a robust growth advantage over wild-type rVSV-MAK-GP on Vero E6 cells. Analysis of complete viral genomes collected from patients in western Africa indicated that this mutation was not found in Ebola virus clinical samples. However, we observed the emergence of T544I during serial passage of various Ebola Makona isolates on Vero E6 cells. Three independent isolates showed emergence of T544I from undetectable levels in nonpassaged virus or virus passaged once to frequencies of greater than 60% within a single passage, consistent with it being a tissue culture adaptation. Intriguingly, T544I is not found in any Sudan, Bundibugyo, or Tai Forest ebolavirus sequences. Furthermore, T544I did not emerge when we serially passaged recombinant VSV encoding GP
from these ebolaviruses. This report provides experimental evidence that the spontaneous mutation T544I is a tissue culture adaptation in certain cell lines and that it may be unique for the species
The Ebola virus (Zaire) species is the most lethal species of all ebolaviruses in terms of mortality rate and number of deaths. Understanding how the Ebola virus surface glycoprotein functions to facilitate entry in cells is an area of intense research. Recently, three groups independently identified a polymorphism in the Ebola glycoprotein (I544) that enhanced virus entry, but they did not agree in their conclusions regarding its impact on pathogenesis. Our findings here address the origins of this polymorphism and provide experimental evidence showing that it is the result of a spontaneous mutation (T544I) specific to tissue culture conditions, suggesting that it has no role in pathogenesis. We further show that this mutation may be unique to the species
, as it does not occur in Sudan, Bundibugyo, and Tai Forest ebolaviruses. Understanding the mechanism behind this mutation can provide insight into functional differences that exist in culture conditions and among ebolavirus glycoproteins.